Application and effect analysis of new fine management mode of antibiotics in our hospital

QUE Fuchang; ZENG Xiaoyun; ZHOU Benjie

doi:10.6039/j.issn.1001-0408.2022.24.21

您当前的位置：

首页 >

文章列表页 >

Application and effect analysis of new fine management mode of antibiotics in our hospital

更新时间：2023-02-22

- Application and effect analysis of new fine management mode of antibiotics in our hospital
- ZHONGGUO YAOFANG Vol. 33, Issue 24, Pages: 3049-3052(2022)
- 作者机构：
  
  中山大学附属第七医院药学部，广东深圳　518107
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2022.24.21
  CLC： R95;R978.1
- Published：30 December 2022，
  
  Received：08 August 2022，
  
  Revised：25 November 2022，
扫描看全文
阙富昌,曾晓云,周本杰.我院新型抗菌药物精细化管理模式应用及效果分析 ^Δ[J].中国药房,2022,33(24):3049-3052.

QUE Fuchang,ZENG Xiaoyun,ZHOU Benjie.Application and effect analysis of new fine management mode of antibiotics in our hospital[J].ZHONGGUO YAOFANG,2022,33(24):3049-3052.
阙富昌,曾晓云,周本杰.我院新型抗菌药物精细化管理模式应用及效果分析 ^Δ[J].中国药房,2022,33(24):3049-3052. DOI： 10.6039/j.issn.1001-0408.2022.24.21.

QUE Fuchang,ZENG Xiaoyun,ZHOU Benjie.Application and effect analysis of new fine management mode of antibiotics in our hospital[J].ZHONGGUO YAOFANG,2022,33(24):3049-3052. DOI： 10.6039/j.issn.1001-0408.2022.24.21.

摘要

目的

为医疗机构提高抗菌药物合理使用水平提供参考。

方法

我院通过借助信息化建设、加强人员培训考核、开展科普宣教、优化药品供应目录、配备专职临床药师、优化考核指标、及时发布药学情报等措施，构建新型抗菌药物精细化管理模式。通过医院信息系统收集我院2020年1－12月（新型抗菌药物精细化管理模式实施前）和2021年1－12月（新型抗菌药物精细化管理模式实施后）的住院患者抗菌药物使用率、抗菌药物使用强度、住院患者医院感染发生率、手术部位感染发生率、抗菌药物医嘱点评合格率、抗菌药物占西药出库总金额的比例等数据，并进行比较。

结果

与2020年相比，2021年我院住院患者抗菌药物使用率由34.94%降至32.44%，抗菌药物使用强度由39.07 DDDs（限定日剂量）降至30.77 DDDs，住院患者医院感染发生率由2.64%降至1.91%，手术部位感染发生率由0.26%下降至0.03%，抗菌药物医嘱点评合格率由93.82%上升至97.75%，抗菌药物占西药出库总金额的比例由14.86%下降至12.51%。

结论

我院通过一系列精细化管理措施，构建了新型抗菌药物精细化管理模式，在保证治疗效果的情况下，提高了抗菌药物的合理使用水平。

Abstract

OBJECTIVE

To provide reference for improving rational use of antibiotics in medical institutions.

METHODS

With the help of information construction， strengthening personnel training and assessment， carrying out science popularization and education， optimizing drug catalogs， equipping full-time clinical pharmacists， optimizing assessment indicators and releasing pharmaceutical information in time， new fine management mode of antibiotics was constructed in our hospital. Through the hospital information system， the relevant data of our hospital in Jan.-Dec. 2020 （before the implementation） and Jan.-Dec. 2021 （after the implementation） were collected and compared， such as utilization rate of antibiotics， intensity of antimicrobial use， the incidence of hospital infection in the inpatients， the incidence of surgical site infection， the qualified rate of antibiotic medical order， and the proportion of antibiotics in the total outbound amount of Western medicine.

RESULTS

Compared with 2020， the utilization rate of antibiotics in hospitalized patients in 2021 decreased from 34.94% to 32.44%， intensity of antimicrobial use decreased from 39.07 DDDs （defined daily doses） to 30.77 DDDs， and the incidence of nosocomial infections among inpatients decreased from 2.64% to 1.91%； the incidence of surgical site infections decreased from 0.26% to 0.03%； the qualified rate of antibiotic medical orders increased from 93.82% to 97.75%； the proportion of antibiotics in the total outbound amount of Western medicine decreased from 14.86% to 12.51%.

CONCLUSIONS

Through a series of fine management measures， our hospital has built a new fine management mode of antibiotics， which has improved the rationality of antibiotics use while ensuring the treatment effect.

关键词

抗菌药物精细化管理合理用药

Keywords

fine managementrational use of medicine

references

陈晔，董四平. 我国三级公立医院绩效考核指标体系解读与评析[J]. 中国卫生政策研究，2020，13（2）：19-25.

国家卫生健康委员会，教育部，财政部，等.关于印发加强医疗机构药事管理　促进合理用药的意见的通知：国卫医发〔2020〕2号[EB/OL].（2020-02-26）[2020-02-28].http：//www.nhc.gov.cn/yzygj/s7659/202002/ea3b96d1ac0-94c47a1fc39cf00f3960e.shtmlhttp://www.nhc.gov.cn/yzygj/s7659/202002/ea3b96d1ac0-94c47a1fc39cf00f3960e.shtml.

陈凡，邓体瑛，郭珩，等. 新型冠状病毒肺炎患者抗菌药物使用情况分析[J]. 医药导报，2020，39（9）：1285-1288.

宋捷，林海，胡晓静，等. 挪威抗菌药物管理经验及对我国的启示[J]. 中国药房，2018，29（10）：1304-1308.

刘东华，全香花，邢晓敏，等. 骨科药物治疗临床路径管理模式的建立与实践[J]. 医药导报，2021，40（1）：139-143.

付伟，陈陶，陈宇，等.2012－2019年湖北省76家妇幼保健院抗菌药物管理成效分析[J].医药导报，2020，39（10）：1438-1441.

刘洪妹. 临床药师参与急诊患者抗菌药物使用的效果[J]. 临床合理用药杂志，2022，15（4）：124-127.

薛云立. 药剂科从业人员参与抗菌药物用药管理的效果分析[J]. 临床医学，2022，42（2）：71-72.

薛颖妍，刘英，谭艳玲. 临床药学干预对降低普通外科抗菌药物使用强度的效果评价[J]. 中国处方药，2021，19（12）：32-33.

沈爱宗，张圣雨，陈泳伍，等. 我院碳青霉烯类抗菌药物专档管理体系的构建与实践[J]. 中国药房，2021，32（12）：1515-1519.

冯惠玲. 抗菌药物使用强度分科分级控制在医院抗菌药物管理中的应用效果[J]. 临床合理用药杂志，2022，15（5）：149-151.

郭立伟，黄涓涓，林小娟. PDCA循环管理法在抗菌药物分级管理中的应用[J]. 江苏卫生事业管理，2022，33（2）：208-211.

钱程，沈君华.品管圈活动对抗菌药物使用强度的影响研究[J].江苏卫生事业管理，2021，32（11）：1491-1494.

吴勤德，吴勇，谢贤宇，等. 某三甲医院实施抗菌药物科学化管理成效研究[J]. 包头医学院学报，2021，37（12）：101-105，119.

王庆庆，张步有，黄剑林，等.某三级医院抗菌药物管理的长期效果[J].临床医学研究与实践，2021，6（35）：195-198.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Application and evaluation of management mode for the use of antimicrobial drugs in county-level medical communities led by anti-infective clinical pharmacists

Expert consensus on comprehensive clinical evaluation of antidepressant drugs

Effect of posaconazole combined with proton pump inhibitors on blood concentrations and invasive fungal infection in patients with malignant hematological disorders

Clinical comprehensive evaluation of Chinese patent medicine for the treatment of chronic hepatitis B

Comparison of two analysis methods of opioid consumption sum in medical institutions

Related Author

DENG Xiaoqin

ZHAO Chi

LI Zhaohong

YAN Hongyan

SHEN Dongfang

TAN Helang

JIANG Mingzhong

DENG Nanjun

Related Institution

Dept. of Pharmacy， Zhongxian People’s Hospital of Chongqing， Chongqing Zhongxian

Psychic Health Research Institute， the Second Xiangya Hospital of Central South University

Shanghai Mental Health Center Affiliated to Shanghai Jiao Tong University School of Medicine/National Center for Mental Disorder

Peking University Sixth Hospital/National Clinical Research Center for Psychiatric and Mental Disorders

Dept. of Hematology， the First Hosptial of Hebei Medical University

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰